You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

GENETIC ASPECTS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE DEVELOPMENT

1(34) 2013

DOI xxxxxxxx

Dolinchuk L. V., Basanets A. V., Andrushchenko T. A.

GENETIC ASPECTS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE DEVELOPMENT

SI «Institute for Occupational Health of NAMS of Ukraine», Kyiv

Full article (PDF), UKR

The literature review covers the data on COPD prevalence, both in Ukraine and abroad. The major risk factors, influencing the disease development as well as COPD of occupational etiology, are highlighted. The literature (home and foreign) on genetic susceptibility to COPD development has been analyzed and characteristic of genes is given, showing the effect of protein products on the key components of the disease pathogenesis.

Key words: COPD, miners, risk factors, susceptibility of biomarkers

References

  1. Aver'yanov A. V. Defitsit ± 1-antitripsina i khronicheskaya obstruktivnaya bolezn' legkikh / A. V. Aver'yanov, A. E. Polivanova // Pul'monologiya.- 2007.- No 3.- S. 103-109.
  2. Aver'yanov A. V. Rol' neytrofil'noy elastazy v patogeneze khronicheskoy obstruktivnoy bolezni legkikh / A. V. Aver'yanov // Tsitokiny i vospaleniye.- 2007.- No 4.- S. 3-8.
  3. Horovenko N.G., Zhurakhivska N.V., Basanets A.V. (2012) “Association between CSTM1, GSTM1, CC1B, TNF-a, Pi genetic polymorphism and coal workers’ pneumoconiosis”, Ukrainian Journal of Occupational Health, 3, 35-42.
  4. Dosvid provedennya hihiyenichnoyi ekspertyzy umov pratsi hirnykiv vuhilʹnykh shakht / Perederiy H. S., Ponomarenko A. M., Shemyakin A. M. [ta in.] // Ukrainsʹkyy zhurnal z problem medytsyny pratsi.- 2008.- No 2 (14).- S. 15-27.
  5. Yermakova O.V. (2011), Chronic obstructive pulmonary disease in coal miners (diagnosis, treatment and prevention), abstract. diss. for the degree of Cand. med. sci., Specialty 02/14/01 Hygiene and Occupational Pathology, Institute of Occup. Health, Kyiv, Ukraine.
  6. Kundiev Yu.I., Nahorna A.M. (2006),”Occupational morbidity in Ukraine under the dynamics of a long-term survey”, Ukrainian Journal of Occupational Health 1, 3-12.
  7. Kundiev Yu.I., Nahorna A.M. (2006), Profesiyne zdorov’ya v Ukraini. Epidemiologichnyi analiz [Occupational health in Ukraine. Epidemiological analysis], Avicenna, Kyiv, Ukraine.
  8. Kundiev Yu.I., Nahorna A.M., Basanets A.V. (2006), Profesiyni zakhvoryuvannya, shcho vynykayutʹ vnaslidok vplyvu pylu [Occupational diseases caused by dust ],Avicenna, Kyiv, Ukraine.
  9. Porivnyalʹni dani pro rozpovsyudzhenistʹ khvorob orhaniv dykhannya i medychnu dopomohu khvorym na khvoroby pulʹmonolohichnoho profilyu v Ukrayini za 2008-2010 rr. / M. I. Lynnyk [ta in.].- K., 2011.- 34 s.
  10. Mazitova N. N. Professional'nyye faktory i khronicheskaya obstruktivnaya bolezn' legkikh: metaanaliz / N. N. Mazitova // Fundamental'nyye issledovaniya.- 2011.- No 9.- S. 588-592.
  11. Opredeleniye nasledstvennoy predraspolozhennosti k nekotorym chastym zabolevaniyam pri beremennosti. Geneticheskaya karta reproduktivnogo zdorov'ya: metodicheskiye rekomendatsii / V. S. Baranov, T E. Ivashchenko, A. S. Glotov [i dr.]; pod red. V. S. Baranova i E. K. Aylamazyana.- SPb: “Izd-vo N-L”, OOO, 2009.- 68 s.: il.- (Seriya Yekh libris “Zhurnal akusherstva i zhenskikh bolezney”).
  12. Sovremennye podkhody k dyahnostyke y lechenyyu KHOZL: ukraynskye spetsyalysty starayut·sya ydty v nohu so vremenem: materialy II Nauk.-prakt. konf. [“Aktualʹni problemy likuvannya khvorykh khronichnym obstruktyvnym zakhvoryuvannyam lehen”], (Kyiv, 12 kvit. 2012 r.). Nats. in-t. ftyz. ta pulʹm. im. F. H. Yanovsʹkoho NAMN Ukrainy.- Zdor. Ukr., 2012.- No 10 (287) - S. 20-22.
  13. Chuchalin A. G. Standarty po diagnostike i lecheniyu bol'nykh khronicheskoy obstruktivnoy bolezn'yu legkikh / Chuchalin A. G,- M.: Atmosfera, 2005.- 96 s.
  14. Yudina L. V. Khronicheskoye obstruktivnoye zabolevaniye legkikh: ne vse tak beznadezhno/ L.V. Yudina // Novosti meditsiny i farmatsii v mire.- 2008.- No 10 (245).- S. 8-9.
  15. A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology / M. M. Gosman, H. M. Boezen, C. C. van Diemen [et al.] // Thorax.- 2007.- V. 62.- P. 242-247.
  16. A Functional Mutation in the Terminal Exon of Elastin in Severe, Early-Onset Chronic Obstructive Pulmonary Disease / C. M. Kelleher, E. K. Silverman, T. Broekelmann [et. al.] // Am J Respir Cell Mol Biol.- 2005.- V. 33.- P. 355-362.
  17. Abboud R. T. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema / R. T. Abboud, S.Vimalanathan // Int. J. Tuberc. Lung Dis.- 2008.- V. 4 (12).- P. 361-367.
  18. Association of IL8, CXCR2 and TNF-a polymorphisms and airway disease / M. C. Matheson, J. A. Ellis, J. E. Raven [et. al.] // J Hum Genet.- 2006.- V. 51.- P. 196-203.
  19. Aging, carotid artery distensibility, and the Ser422Gly elastin gene polymorphism in humans / O. Hanon, V. Luong, J. J. Mourad [et al.] // Hypertension.- 2001.- V. 38.- P. 1185-1189.
  20. Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population / M. Manetti, Ibba-Manneschi, C. Fatini [et al.] // J. rheumatol.- 2010.- V.37 (9).- P. 1852-1857.
  21. Alpha 2-macroglobulin: a sensor for proteolysis / C. T Chu, G. C. Howard, U. K. Misra, S. V. Pizzo // Ann N Y Acad Sci.- 1994 - V. 737.- P. 291-307.
  22. An understanding of the genetic basis of asthma / Mahdi Bijanzadeh, Padukudru A. Mahesh, Nallur B. Rama- chandra // Indian J Med Res.- 2011.- V. 134(2).- P. 149-161.
  23. Analysis of Exonic Elastin Variants in Severe, Early-Onset Chronic Obstructive Pulmonary Disease / M. H. Cho, D. M. Ciulla, B. J. Landerman [et. al.] // Am J. Respir Cell Mol Biol.- 2009.- V. 40.- P. 751-755.
  24. Association analysis of tissue inhibitor of metallo- proteinase2 gene polymorphisms with COPD in Egyptians // A. E. Hegab, T. Sakamoto, Y. Uchida [et al.] // Respir. Med.- 2005.- V. 99.- P. 107-110.
  25. Association of MMP - 12 polymorphisms with severe and very severe COPD: A case control study of MMPs - 1, 9 and 12 in a European population / I. Haq, S. Chappell, S.R. Johnson [et al.] // BMC Med Genet.- 2010.- V. 11.- P.7.
  26. Bhupinder S. S. Matrix metalloproteinases - an overview / S. S. Bhupinder // Research and Reports in Biology - 2010.- V. 2010 - P. 1-20.
  27. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease / M. C. Matheson [et al.] // Thorax.- 2005.- V. 60.- P. 645-651.
  28. Brinckerhoff C. E. Matrix metaloproteinases: a tail of frog that became a prince / C. E. Brinckerhoff, M. Matrisian // Nature Reviews Molecular Cell Biology- 2002.- V. 3.- P. 207-214.
  29. Candidate genes for COPD in two large data sets / P. S. Bakke, G. Zhu, A. Gulsvik [et. al.] // Epub.- 2011.- V. 37 (2).- P. 255-263.
  30. Chronic obstructive pulmonary disease (COPD) and occupational exposures / Boschetto P, Quintavalle S, Miotto D. [et al.] // J Occup Med Toxicol.- 2006.- V. 7.- P. 1-11.
  31. Cloning of the human alpha 2-macroglobulin gene and detection of mutations in two functional domains: the bait region and the thiolester site / W. Poller, J. P. Faber, G. Klobeck, K. Olek // Hum Genet.- 1992.- V. 88.- P. 313-319.
  32. Combinatorial effect of TIMP-1 and a (1) AT gene polymorphisms on development of chronic obstructive pulmonary disease / M. Kumar, D. P. Bhadoria, K. Dutta [et al.] // Clin Biochem.- 2011.- V. 44.- P. 1067-1073.
  33. Comparison of smoker and nonsmoker lavage fluid for the rate of association with neutrophil elastase / M. D. Wewers, D. J. Herzyk, J. E. Gadek // Am J Respir Cell Mol Biol.- 1989.- V. 1(5).- P. 423-429.
  34. Decorin and TGF-b1 polymorphisms and development of COPD in a general population / van Diemen C. C, Postma D. S, Vonk J. M. [et al.] // Respir Res.- 2006.- V. 7.- P. 89.
  35. Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors / E. Nuti, L. Panelli, F. Casalini [et al.] // J.Med. Chem.- 2009.-52, (20).- P. 6347-6361.
  36. Developing COPD: a 25 year follow up-study of the general population / A. Lokke, P. Lange, H. Scharling [et al.] // Thorax.- 2006.- V. 61.- P. 935-939.
  37. Eduard W. Chronic Bronchitis, COPD and Lung Function in Farmers: The Role of Biological Agents / W. Eduard, N. Pearce, J.Douwes // Chest.- 2009.- V. 58 (6).- P. 24.
  38. Elkington P. T. G. Matrix metalloproteinases in destructive pulmonary pathology / P. T. G. Elkington, J. S. Friedland // Thorax.- 2006.- V. 61.- P. 259-266.
  39. Faurschou M. Neutrophil granules and secretary vesicles in inflammation / M. Faurschou, N. Borregaard // Microbes Infect.- 2003.- V. 5.- P. 1317-1327.
  40. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm / Peters D. G., Kassam A., St Jean P. L. [et al] // Stroke.- 1999.- V. 30 (12).- P. 2612-2616.
  41. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis / B. Zhang, S. Ye, S. M. Herrmann [et al.] // Circulation.- 1999.- V. 99.- P.1788-1794.
  42. Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease / A. Liao, R. M. Nitsch., S. M. Greenberg [et al.] // Hum Mol Genet.- 1998. -V. 7.- P. 1953-1956.
  43. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema / N. Minematsu, H. Nakamura, H. Tateno, T. Nakajima, K. Yamaguchi // Biochem Biophys Res Commun.- 2001.- V. 289 (1).- P. 116-119.
  44. Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China / M. Zhou, S. G. Huang, H. Y. Wan [et al.] // Chin Med J (Engl).- 2004.- V. 117.- P. 1481-484.
  45. Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD / A. Vibhuti, E. Arif, D. Deepak [et al.] // Biochem Biophys Res Commun.- 2007.- V. 359.- P. 136-142.
  46. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1 / B. Zhang, A. Henney, P. Eriksson [et al.] // Hum Genet.- 1999.- V. 105.- P. 418-423.
  47. Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts / van Diemen C. C., Postma D. S., Siedlinski M. [et al.] // Respir Res.- 2011.- V.12.- P. 57-60.
  48. Global burden of COPD: systematic review and meta-analysis / R. J. Halbert, J. L. Natoli, A. Gano [et al.] // Eur Respir J.- 2006.- V. 28.- P. 523-532.
  49. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy or the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease. NHLBI/ WHO workshop report. Last update 2008. [Electron. resource] .- Access mode: http://www.goldcopd.com.
  50. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy or the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease. NHLBI/ WHO workshop report. Last update 2011. [Electron. resource] .- Access mode: http://www.goldcopd.com.
  51. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. National Heart, Lung and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD). Executive Summary / R. Pauwels [et al.].- 2004.
  52. Glutathione S-transferase M1 and T1 gene polymorphism and COPD risk in smokers: an updated analysis / H. Xue, J. Su, K. Sun [et al.] // Mol Biol Rep.- 2012.- V. 39 (4).- P. 5033-5042.
  53. Heme oxygenase 1 variations and lung function decline in smokers: proof of replication / M. Siedlinski, C. C. van Diemen, D. S. Postma [et al.] // J Med Genet- 2008.- V. 45.- P. 400.
  54. Hersh C. P. Genetic Association Analysis of Functional Impairment in Chronic Obstructive Pulmonary Disease / C. P. Hersh, D. L. DeMeo, R. Lazarus // Am. J. Respir Crit Care Med.- 2006.- V. 173.- P. 977-984.
  55. Highly variable cutis laxa resulting from a dominant splicing mutation of the elastin gene / L. M. Graul-Neumann, I. Hausser, M. Essayie [et. al.] // Am. J. Med Genet A.- 2008.- V. 146A.- P. 977-983.
  56. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era / K. H. L. Crothers, J. L. Goulet, M. B. Goets, S. T Brown // Am. J Respir Crit Care Med.- 2011.- V. 183 - P. 388-395.
  57. http://www.ncbi.nlm.nih.gov/gene/
  58. Impaired distal airway development in mice lacking elastin / D. P. Wendel, D. G. Taylor, K. H. Albertine [et al.] // Am J Respir Cell Mol Biol.- 2000.- V. 23.- P. 320-326.
  59. Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models / M. Lucattelli, B. Bartalesi, E. Cavarra [et. al.] // Respir Res.- 2005.- V. 6 (1).- P. 83.
  60. Janoff A. Elastases and emphysema: current assessment of the proteaseantiprotease hypothesis / A. Janoff // Am Rev Respir Dis.- 1985.- V. 132.- P. 417-433.
  61. Mathers C. D. Projections of global mortality and burden of disease from 2002 to 2030 / C. D. Mathers, D. Loncar // PloS Med.- 2006 - V. 3.- P. 442.
  62. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema / Ito, S. Nagai, T Handa [et al.] // Am. J. Respir Crit Care Med.- 2005.- V. 172.- P. 1378-1382.
  63. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema // K. Ohnishi, M. Takagi, Y. Kurokawa [et al.] // Lab Invest.- 1998.- V. 78 - P. 1077-1087.
  64. Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications/ S. Oikonomidi, K. Kostikas, I. Tsilioni [et al.] // Cur Med. Chem.- 2009.- V. 16 (10).- P. 1214-1228.
  65. Matthijs G. A deletion polymorphism in the human alpha-2-macroglobulin (A2M) gene / Matthijs G., Marynen P. // Nucleic Acids Res.- 1991.- V. 19 (18).- P. 5102.
  66. Murphy G. Tissue inhibitors of metalloproteinases Murphy Genome Biology / Murphy G. // BioMed Central Ltd.- 2011.- V. 12.- P.233.
  67. Neutrophil elastase in cyclic and severe congenital neutropenia / M. S. Horwitz, Z. Duan, B. Korkmaz [et al.] // Blood.- 2007.- V. 109 (5).- P. 1817-1824.
  68. Neutrophil Elastase-Mediated Degradation of IRS-1 Accelerates Lung Tumor Growth / A. McGarry Houghton, Danuta M. Rzymkiewicz, Hongbin Ji [et al.] // Nat Med.- 2010 - V. 16(2) - P. 219-223.
  69. Patten R. Cellular, molecular and structural changes during cardiac remodeling / R. Patten // Congestive heart failure / J. Hosenpud, B. Greenberg.- [3rd Ed.].- 2007.- P. 128-146.
  70. Polymorphisms in matrix metalloproteinase-1, _9 and _12 genes and the risk of chronic obstructive pulmonary disease in a Korean population / S. Y. Lee, M., J. Kim, H. G. Kang [et al.] // Respiration.- 2010.- V. 80.- P. 133-138.
  71. Polymorphisms in the human surfactant protein-D (SFTPD) gene: strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced / Heidinger K., Konig I.R., Bohnert A. [et al.] // Immunogenetics. 2005.- V. 57.- P. 1-7.
  72. Polymorphisms in the promoter region of neutrophil elastase gene and lung cancer risk / Parka J. Y., Chena Lan, Leeb JiHyun [et al.] // Tockmana Lung Cancer.- 2005.- V. 48.- P. 315-321.
  73. Polymorphisms in the promoter region of the neutrophil elastase gene are associated with lung cancer development / K. Taniguchi, P. Yang, J. Jett [et al.] // Clin Cancer Res.- 2002.- V. 8.- P. 1115-1120.
  74. Rashton L. Occupational causes of obstructive pulmonary disease / L. Rashton // Rev Environ Helth.- 2007.- P. 195-212.
  75. Risk factors for chronic obstructive pulmonary disease in European cohort of young adults / R. de Marco, S. Accordina, A. Marcon [et al.] // Am. J. Respir Crit Care Med.- 2011.- V. 183.- P. 891-897.
  76. Ross M. H. Occupational respiratory disease in mining / Ross M. H., Murray J. // Occup Med (Lond).- 2004.- V. 54 (5).- P. 304-310.
  77. Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor- related protein suggests that this molecule is a multifunctional receptor / D. K. Strickland, J. D. Ashcom, S. Williams [et al.] // J Biol Chem.- 1990.- V. 265.- P. 17401-17404.
  78. SERPINE2 haplotype as a risk factor for panlobular type of emphysema / M. K. Kukkonen, E. Tiili, S. Hamaainen [et. al.] // BMC Med Genet.- 2011.- V. 12.- P. 157.
  79. Sethi S. Infection in the pathogenesis and course of chronic obstructive pulmonary disease / S. Sethi, T. F. Murphy // N Engl J Med.- 2008.- V. 359.- P. 2355-2365.
  80. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population / X. Guo, H. M. Lin, Z. Lin [et al.] // Eur Respir J.- 2001.- V. 18.- P. 482-490.
  81. Tang Z. Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment / Z. Tang, R. P. Tracy // J Thromb Thrombolysis.- 2001.- V. 11 (1) - P. 49-81.
  82. The association of genome-wide significant spirometric loci with COPD susceptibility / P- J. Castaldi, M. H. Cho, A. A. Litonjua [et al.] // Am. J. Respir Cell Mol Biol.- 2011.- V. 45.- P. 1147-1153.
  83. The dual role of neutrophil elastase in lung destruction and repair / G. Lungarella, E. Cavarra, M. Lucattelli, P.A. Martorana // Int J Biochem Cell Biol.- 2008.- V. 40 (6-7).- P. 1287-96.
  84. The occupational burden of chronic obstructive pulmonary disease / Trupin L., Earnest G., San Pedro M. [et al.] // Eur Respir J. 2003.- V. 22 (3).- P. 462-469.
  85. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function / L. Joos, J. Q. He, M. B. Shepherdson [et al.] // Hum Mol Genet- 2003.- V. 12.- P. 803-804.
  86. Tissue inhibitor of metalloproteinases-2gene polymorphisms in chronic obstructive pulmonary disease / K. Hirano, T Sakamoto, Y. Uchida [et al.] // Eur Respir J.- 2001.- V. 18.- P. 748-752.
  87. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America // A. M. Menezes, P. C. Hallal, R. Perez-Padilla [et al.] // Eur Respir J.- 2007.- V. 30.- P. 1180-1185.
  88. Vitamin D receptor gene polymorphisms, bone turnover, and fates of bone loss in older African-American women / J. M. Zmuda, A. Cauley, E. M. Danielson [et al.] // J. Bone Miner. Res.- 1997.- V. 12, No 9.- P. 1446.
  89. Wallace A. M. Genetic polymorphisms of matrix metalloproteinases: functional importance in the development of chronic obstructive pulmonary disease? / A. M. Wallace, A. J. Sandford // Am. J. Pharmacogenomics.- 2002.- V. 2 (3).- P. 167-75.